Latest Beta blockers Stories
DUBLIN, Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the Company has received a complete response letter from the U.S.
Expect to file in the U.S. in First Half of Q2 2015 Expect to launch in the U.S. in First Half of 2016 Peak U.S.
DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the U.S.
The initial results of this trial were published a few months ago (Circulation. 2013;128:1495-1503), and showed that patients who received this treatment during emergency transit to hospital had much smaller amounts of dead heart muscle than those randomly assigned to receive no treatment.
Collaborative Study by Spain and Icahn School of Medicine at Mount Sinai Shows Potential Benefits of Administering Beta-Blocker Medication to Heart Attack Patients in Ambulance New
Patients at elevated cardiac risk who were treated with beta-blockers on the day of or following noncardiac, nonvascular surgery had significantly lower rates of 30-day mortality and cardiac illness.
Baylor College of Medicine researchers will lead a three-year, $4.2 million study funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to determine whether drugs called beta blockers can ease airway narrowing in patients with asthma and examine potential mechanisms.
Information released Monday, January 7, shows that there may be a connection between taking the blood pressure drugs beta blockers and a reduced risk for Alzheimer’s disease and other types of dementia.
First developed in the 1950s, beta blockers have been a mainstay in medicine for decades, used to treat everything from heart disease to stage fright to glaucoma.
A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.